Skip to main content

News

Where hypotheses become headlines: Featured coverage of the breakthroughs—and the people—driving our research forward

For media inquiries, email us: [email protected]


Featured News
Scripps Research scientists train the immune system to make antibodies against numerous HIV strains
News

Scripps Research scientists train the immune system to make antibodies against numerous HIV strains

Joan Pulupa. Credit: Timothy White
News

Joan Pulupa joins Scripps Research faculty to study the organization of DNA in brain cells and its links to neurodegeneration

Filter by:
  • News

    Potential Drug Candidates Halt Prostate and Breast Cancer Growth

    Next, the researchers plan to further develop their molecule-screening strategy into a platform to test molecules against any form of RNA defect-related disease.

  • News

    TSRI Chemists Unveil Versatile New Method for Making Chiral Drug Molecules

    "This method essentially mimics the ability of the enzymes in our cells to turn simple organic molecules into chiral molecules."

  • News

    Scripps Florida Team Awarded $1.8 Million Grant to Develop Drugs for Heart Disease and Rheumatoid Arthritis

    The co-principal investigators of the three-year project are TSRI Professor William R. Roush and Associate Professor Derek Duckett.

  • New TSRI Method Could Turbocharge Drug Discovery, Protein Research
    News

    New TSRI Method Could Turbocharge Drug Discovery, Protein Research

    A team led by scientists at Scripps Research has developed a versatile new method that should enhance the discovery of new drugs and the study of proteins.

  • The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology
    News

    The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology

    The Scripps Research Institute (TSRI), a leading non-profit biomedical research institute, today announced a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to pioneer new DNA-encoded library (DEL) technology.

  • News

    Calibr News: Intarcia and Calibr Announce New Collaboration and In-Licensing Deal

    Calibr, a corporate affiliate of The Scripps Research Institute, has announced a strategic research collaboration with Intarcia Therapeutics, Inc.

  • News

    TSRI Scientists Devise New Approaches to Personalized Medicines

  • News

    Scripps Florida Scientists Create Innovative Drug Design Strategy to Improve Breast Cancer Treatment

  • TSRI Study Suggests Repurposed Deworming Drugs Could Combat <i>C. Difficile</i> Epidemic
    News

    TSRI Study Suggests Repurposed Deworming Drugs Could Combat C. Difficile Epidemic

  • New TSRI Method Makes Building ‘One-Handed’ Drugs Easier than Ever
    News

    New TSRI Method Makes Building ‘One-Handed’ Drugs Easier than Ever

  • Scripps Florida Study Finds &#8216;Missing Evolutionary Link&#8217; of a Widely Used Natural Drug Source
    News

    Scripps Florida Study Finds ‘Missing Evolutionary Link’ of a Widely Used Natural Drug Source

  • News

    Study Suggests New Drug Candidate Could Treat Both Type 2 Diabetes and Bone Loss

Groundbreaking Science.
Life-changing Medicine.